A detailed history of North Point Portfolio Managers Corp transactions in Danaher Corp stock. As of the latest transaction made, North Point Portfolio Managers Corp holds 69,039 shares of DHR stock, worth $16.5 Million. This represents 3.25% of its overall portfolio holdings.

Number of Shares
69,039
Previous 68,860 0.26%
Holding current value
$16.5 Million
Previous $17.2 Million 11.56%
% of portfolio
3.25%
Previous 3.06%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$239.25 - $280.76 $42,825 - $50,256
179 Added 0.26%
69,039 $19.2 Million
Q2 2024

Jul 29, 2024

SELL
$235.51 - $267.98 $219,966 - $250,293
-934 Reduced 1.34%
68,860 $17.2 Million
Q1 2024

Apr 23, 2024

BUY
$224.58 - $256.19 $12,351 - $14,090
55 Added 0.08%
69,794 $17.4 Million
Q4 2023

Jan 23, 2024

SELL
$185.1 - $233.13 $50,717 - $63,877
-274 Reduced 0.39%
69,739 $16.1 Million
Q3 2023

Oct 26, 2023

SELL
$233.08 - $265.59 $139,848 - $159,353
-600 Reduced 0.85%
70,013 $17.4 Million
Q2 2023

Jul 24, 2023

SELL
$224.99 - $256.14 $4.36 Million - $4.97 Million
-19,398 Reduced 21.55%
70,613 $16.9 Million
Q1 2023

Apr 25, 2023

BUY
$239.75 - $277.0 $54,423 - $62,879
227 Added 0.25%
90,011 $22.7 Million
Q4 2022

Jan 24, 2023

SELL
$241.42 - $282.29 $32,591 - $38,109
-135 Reduced 0.15%
89,784 $0
Q3 2022

Oct 25, 2022

SELL
$247.06 - $1507.4 $349,589 - $2.13 Million
-1,415 Reduced 1.55%
89,919 $23.2 Million
Q2 2022

Jul 27, 2022

SELL
$237.11 - $299.66 $316,778 - $400,345
-1,336 Reduced 1.44%
91,334 $23.2 Million
Q1 2022

Apr 26, 2022

SELL
$257.27 - $315.76 $145,614 - $178,720
-566 Reduced 0.61%
92,670 $27.2 Million
Q4 2021

Jan 26, 2022

SELL
$292.08 - $329.01 $1.34 Million - $1.51 Million
-4,602 Reduced 4.7%
93,236 $30.7 Million
Q3 2021

Oct 20, 2021

SELL
$272.21 - $332.43 $4.98 Million - $6.08 Million
-18,283 Reduced 15.74%
97,838 $29.8 Million
Q2 2021

Jul 28, 2021

BUY
$225.08 - $271.69 $106,237 - $128,237
472 Added 0.41%
116,121 $31.2 Million
Q1 2021

Apr 26, 2021

SELL
$212.38 - $245.9 $55,643 - $64,425
-262 Reduced 0.23%
115,649 $26 Million
Q4 2020

Jan 28, 2021

BUY
$212.5 - $245.46 $10,412 - $12,027
49 Added 0.04%
115,911 $25.7 Million
Q3 2020

Oct 27, 2020

SELL
$177.16 - $215.33 $3.32 Million - $4.03 Million
-18,723 Reduced 13.91%
115,862 $24.9 Million
Q2 2020

Jul 28, 2020

SELL
$128.7 - $176.83 $582,882 - $800,863
-4,529 Reduced 3.26%
134,585 $23.8 Million
Q1 2020

Apr 28, 2020

SELL
$121.39 - $169.05 $244,358 - $340,297
-2,013 Reduced 1.43%
139,114 $19.3 Million
Q4 2019

Feb 20, 2020

BUY
$133.47 - $153.48 $14,147 - $16,268
106 Added 0.08%
141,127 $21.7 Million
Q3 2019

Oct 31, 2019

SELL
$135.4 - $146.47 $119,422 - $129,186
-882 Reduced 0.62%
141,021 $20.4 Million
Q2 2019

Aug 02, 2019

SELL
$124.88 - $143.73 $3.34 Million - $3.84 Million
-26,715 Reduced 15.84%
141,903 $20.3 Million
Q1 2019

Apr 24, 2019

BUY
$97.62 - $132.29 $105,331 - $142,740
1,079 Added 0.64%
168,618 $22.3 Million
Q4 2018

Jan 24, 2019

SELL
$94.85 - $109.54 $1.23 Million - $1.42 Million
-12,946 Reduced 7.17%
167,539 $17.3 Million
Q3 2018

Oct 26, 2018

SELL
$98.13 - $108.9 $637,256 - $707,196
-6,494 Reduced 3.47%
180,485 $19.6 Million
Q2 2018

Jul 26, 2018

SELL
$96.1 - $103.24 $212,188 - $227,953
-2,208 Reduced 1.17%
186,979 $18.5 Million
Q1 2018

Apr 25, 2018

SELL
$92.16 - $103.8 $263,577 - $296,868
-2,860 Reduced 1.49%
189,187 $18.5 Million
Q4 2017

Jan 24, 2018

SELL
$85.26 - $94.62 $822,076 - $912,326
-9,642 Reduced 4.78%
192,047 $17.8 Million
Q3 2017

Oct 30, 2017

BUY
$79.29 - $88.45 $16 Million - $17.8 Million
201,689
201,689 $17.3 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $174B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track North Point Portfolio Managers Corp Portfolio

Follow North Point Portfolio Managers Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Point Portfolio Managers Corp, based on Form 13F filings with the SEC.

News

Stay updated on North Point Portfolio Managers Corp with notifications on news.